Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of VEGFB associated with NKT cells in diabetic foot ulcers: Single-cell analysis and machine learning. | Medicine (Baltimore) | 2026 | 41686577 | PubTator, text mining | PubMed |
| Predictive value of miR-193a-5p combined with VEGFB in the diagnosis and prognosis of CHD. | J Cardiothorac Surg | 2026 | 41668198 | PubTator, text mining | PubMed |
| Spatial transcriptomics identifies IL-32 as a lipid droplet-associated cytokine linked to tubular injury in human diabetic kidney disease. | Inflamm Res | 2026 | 41653322 | PubTator, text mining | PubMed |
| Gene Therapy for Heart Failure. | J Cardiovasc Transl Res | 2026 | 41642391 | PubTator, text mining | PubMed |
| Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. | J Immunother Cancer | 2026 | 41629132 | PubTator, text mining | PubMed |
| Multimodal Imaging Studies of Pigmented Paravenous Retinochoroidal Atrophy: A Case Report. | Am J Case Rep | 2026 | 41622658 | PubTator, text mining | PubMed |
| Multi-omic expression of the VEGF family relates to Alzheimer's disease across diverse populations. | Alzheimers Dement | 2026 | 41603414 | PubTator, text mining | PubMed |
| In vitro generated macrophages reflect the immunosuppressive phenotype of in vivo glioblastoma-associated macrophages. | Oncoimmunology | 2026 | 41582518 | PubTator, text mining | PubMed |
| The protective effect of maternal electroacupuncture on prenatal nicotine exposure-induced intrauterine growth restriction in rats by improving placental angiogenesis. | Chin Med | 2026 | 41572301 | PubTator, text mining | PubMed |
| Benign prostatic hyperplasia to HPIN to carcinoma; the impact of mast cells and VEGF. | Diagn Pathol | 2026 | 41559778 | PubTator, text mining | PubMed |
| Serum N-glycan NA3Fb identified as a prognostic biomarker of poor outcome in HBV-related hepatocellular carcinoma. | Cancer Cell Int | 2026 | 41559758 | PubTator, text mining | PubMed |
| Evaluation of CendR peptides mined from protein databases as potential inhibitors of neuropilin-1 using an in-silico molecular modeling approach. | J Mol Graph Model | 2026 | 41558186 | PubTator, text mining | PubMed |
| Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial. | NPJ Precis Oncol | 2026 | 41530374 | PubTator, text mining | PubMed |
| PTG-Dependent Glycogen Metabolic Dysfunction Drives Impaired Adipose Browning: A Novel Mechanism Linking PM2.5 to Metabolic Disorders. | Adv Sci (Weinh) | 2026 | 41514494 | PubTator, text mining | PubMed |
| VEGF-B: A multifaceted modulator with emerging therapeutic applications. | Pharmacol Res | 2026 | 41386311 | PubTator, text mining | PubMed |
| In Silico Identification of 9-Amino Camptothecin as a Dual Inhibitor of VEGF-A and VEGF-B in N1-N8 Breast Cancer. | Biotechnol Appl Biochem | 2026 | 41147711 | PubTator, text mining | PubMed |
| Integrative Single-Cell and Spatial Transcriptomics Reveal Functional and Spatial Heterogeneity of Atrial and Ventricular Cardiomyocytes in the Heart. | Mol Biotechnol | 2026 | 40488964 | PubTator, text mining | PubMed |
| Effects of acupuncture and moxibustion therapy on endometrial receptivity of infertile women with in vitro fertilization-embryo transfer: status quo and countermeasures. | Front Med (Lausanne) | 2025 | 41743455 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Profiling of main regulators of angiogenesis and inflammation in human PBMC and plasma revealed associations with lower extremity artery disease. | Sci Rep | 2025 | 41290770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=3